← SynDRA
I-CBP112
SynDRA canonical compound SYN0062784 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CREBBP | EP300 |
|---|
| Mechanism of action | bromodomain inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- CREBBP INHIBITOR
- EP300 INHIBITOR
- BET bromodomain inhibitor
- KAT6B INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- GTPL8236
- I-CBP 112
- CHEMBL3774655
- 1-[7-(3,4-Dimethoxyphenyl)-9-[[(3S)-1-methylpiperidin-3-yl]methoxy]-2,3,4,5-tetrahydro-1,4-benzoxazepin-4-yl]propan-1-one
- 1-[7-(3,4-dimethoxyphenyl)-9-{[(3S)-1-methylpiperidin-3-yl]methoxy}-2,3,4,5-tetrahydro-1,4-benzoxazepin-4-yl]propan-1-one
- SCHEMBL17620385
- MolPort-035-765-871
- EX-A2474
- ZINC96024493
- BDBM50151663
- AKOS024458402
- CS-6146
- NCGC00350526-04
- HY-19541
- I-CBP112, >
- I-CBP-112
- RefChem:147542
- MFCD26792587
- orb1303497
- SCHEMBL29403457
- I-CBP112?
- GLXC-05264
- HB1447
- s6758
- NCGC00350526-06
- AC-36087
- AS-82583
- BP-25357
- DA-74393
- I-CBP112, >=98% (HPLC)
- T3969
- N16993
- SCHEMBL26548058
- BDBM50266292
Look up I-CBP112 in the interactive SynDRA portal →